Literature DB >> 16730795

Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis.

Martin Schwonzen1, Volker Diehl, Mario Dellanna, Peter Staib.   

Abstract

Immunophenotyping of acute leukemia using flow cytometry after density gradient separation (dg-sep) of mononuclear cells is the international gold standard. But destroying red cells by whole blood lysis (wb-lysis) after direct staining has found a broad usage. Both methods revealed congruent results in phenotyping of 26 cases of acute myeloid leukemias by testing CD4, CD7, CD11b, CD11c, CD13, CD14, CD15, CD33, CD34, CD65s, Glycophorin A and HLA-DR antigens. Mean values of these tested antigens were very similar. Only low antigen expression of CD2 was missed in the phenotype of two AML cases by the wb-lysis (23 and 29% positive cells by the dg-sep).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730795     DOI: 10.1016/j.leukres.2006.03.022

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia.

Authors:  S S Kenderian; M Ruella; O Shestova; M Klichinsky; V Aikawa; J J D Morrissette; J Scholler; D Song; D L Porter; M Carroll; C H June; S Gill
Journal:  Leukemia       Date:  2015-02-27       Impact factor: 11.528

Review 2.  Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies.

Authors:  Antonia Rotolo; Anastasios Karadimitris; Marco Ruella
Journal:  Leuk Lymphoma       Date:  2017-11-22

3.  Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.

Authors:  Brian A Webber; Melissa M Cushing; Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

4.  Decreased classical monocytes and CD163 expression in TB patients: an indicator of drug resistance.

Authors:  Faheem Shahzad; Noman Bashir; Atia Ali; Shagufta Jabeen; Mohammad Kashif; Khursheed Javaid; Romeeza Tahir; Afia Abbas; Shah Jahan; Nadeem Afzal
Journal:  Braz J Microbiol       Date:  2021-02-13       Impact factor: 2.476

Review 5.  Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.

Authors:  Nan Li; Madeline R Spetz; Dan Li; Mitchell Ho
Journal:  Pharmacol Ther       Date:  2021-05-14       Impact factor: 13.400

6.  Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia.

Authors:  A Ehninger; M Kramer; C Röllig; C Thiede; M Bornhäuser; M von Bonin; M Wermke; A Feldmann; M Bachmann; G Ehninger; U Oelschlägel
Journal:  Blood Cancer J       Date:  2014-06-13       Impact factor: 11.037

7.  Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system.

Authors:  Luca Basso-Ricci; Serena Scala; Raffaella Milani; Maddalena Migliavacca; Attilio Rovelli; Maria Ester Bernardo; Fabio Ciceri; Alessandro Aiuti; Luca Biasco
Journal:  Cytometry A       Date:  2017-06-13       Impact factor: 4.355

Review 8.  Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia.

Authors:  Mingxue Fan; Minghao Li; Lipeng Gao; Sicong Geng; Jing Wang; Yiting Wang; Zhiqiang Yan; Lei Yu
Journal:  J Hematol Oncol       Date:  2017-08-29       Impact factor: 17.388

Review 9.  The expansion of targetable biomarkers for CAR T cell therapy.

Authors:  Michelle H Townsend; Gajendra Shrestha; Richard A Robison; Kim L O'Neill
Journal:  J Exp Clin Cancer Res       Date:  2018-07-21

Review 10.  A general view of CD33+ leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy.

Authors:  Ezzatollah Fathi; Raheleh Farahzadi; Roghayeh Sheervalilou; Zohreh Sanaat; Ilja Vietor
Journal:  Blood Res       Date:  2020-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.